Eureka Therapeutics Competitors and Similar CompaniesClear all

Immatics's competitors and similar companies include MABION and Lion TCR.
Immatics
Immatics
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
MABION
MABION
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
Lion TCR
Lion TCR
Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
München, DE
Houston, US
Locations
Konstantynów Łódzki, PL HQ
Locations
Singapore, SG HQ
Guangzhou, CN
Singapore, SG
Singapore, SG
Employees
Employees
29723% increase
Employees
95
Employees
N/A
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
21.7 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
€155.8m (FY, 2024)
Revenue (est.)
zł69m (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
zł19.2m (FY, 2024)
Cost of goods
N/A
Gross profit
Gross profit
€155.9m (FY, 2024)
Gross profit
zł50.4m (FY, 2024)
Gross profit
N/A
Net income
Net income
€15.2m (FY, 2024)
Net income
(zł6.3m) (FY, 2024)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 267.3m
Total funding raised
N/A
Total funding raised
$ 20m
For sources of this data, please see the company profile

View Company Profiles

MABION
HQ
Konstantynów Łódzki, PL
Employees
95

Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.

View company
Lion TCR
HQ
Singapore, SG

Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.

View company